Downregulation of the steroidogenic regulator PDE8B, for example, explains the increased membrane fluidity in ovarian cancer cells, which has potential applications in the development of new biomarkers and treatment of ovarian cancer and deserves further investigation (Pampalakis et al., 2015). This evidence concerns the gene PDE8B and ovarian carcinoma.